Roth Capital Upgrades Cogentix Medical (CGNT) to Buy
Tweet Send to a Friend
Roth Capital upgraded Cogentix Medical (NASDAQ: CGNT) from Neutral to Buy with a price target of $3.00 (from $1.85).Analyst Chris ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


